1999
DOI: 10.1161/01.str.30.10.2186
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Estrogen Treatment Increases Levels of Endothelial Nitric Oxide Synthase Protein in Rat Cerebral Microvessels

Abstract: Chronic estrogen treatment increases levels of eNOS protein in cerebral microvessels of male and female rats. This increase in eNOS protein correlates with our previous functional findings indicating that estrogen exposure increases NO modulation of cerebrovascular reactivity in both male and female animals. Upregulation of eNOS expression may contribute to the neuroprotective effect of estrogen.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

11
124
4
2

Year Published

2002
2002
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 154 publications
(141 citation statements)
references
References 23 publications
11
124
4
2
Order By: Relevance
“…However, other studies noted that the effects of 17β-estradiol on vessels display 'regional heterogeneity effects' (Tatchum-Talom et al, 2002). Explanations regarding the protective effects of 17β-estradiol have been offered by several authors on the basis of the NO or NOS-dependent pathway (Beyer et al, 2001;Geary et al, 2000;McNeill et al, 1999) and Ca 2+ transport mechanisms (Crews et al, 1999;Murphy et al, 2000;Tep-areenan et al, 2003). Consequently, we hypothesized that the effects of 17β-estradiol may influence several pathways of the contractile system in vascular smooth muscle.…”
Section: Discussionmentioning
confidence: 95%
“…However, other studies noted that the effects of 17β-estradiol on vessels display 'regional heterogeneity effects' (Tatchum-Talom et al, 2002). Explanations regarding the protective effects of 17β-estradiol have been offered by several authors on the basis of the NO or NOS-dependent pathway (Beyer et al, 2001;Geary et al, 2000;McNeill et al, 1999) and Ca 2+ transport mechanisms (Crews et al, 1999;Murphy et al, 2000;Tep-areenan et al, 2003). Consequently, we hypothesized that the effects of 17β-estradiol may influence several pathways of the contractile system in vascular smooth muscle.…”
Section: Discussionmentioning
confidence: 95%
“…In regards to the influence of androgens on eNOS expression, increase (Simoncini et al 2003), decrease (Chatrath et al 2003) or no change (McNeill et al 1999) have all been reported. We found that aortic eNOS expression was not modified by orchidectomy as has been observed in rat mesenteric artery (Blanco-Rivero et al 2006), but in contrast to observations of nNOS expression in rat mesenteric artery , thus indicating that endogenous male sex hormones act differently, depending on tissue and target protein.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, increase (Simoncini et al 2003), decrease (Chatrath et al 2003) or no change (McNeill et al 1999) of eNOS expression by androgenic derivatives have all been described. Likewise, increase (Liu & Dillon 2002, Simoncini et al 2003 or decrease of eNOS activity by androgens has both been reported.…”
Section: Introductionmentioning
confidence: 99%
“…Data from the Women's Health Initiative suggest that estrogen replacement can increase risk for stroke (Wassertheil-Smoller et al, 2003), but definitive effects on recovery from stroke have yet to be established. The vasorelaxant properties of estrogen have been well studied in most vascular beds, including cerebral vessels (Geary et al, 2000;Pelligrino et al, 2000;Ospina et al, 2003), and are likely orchestrated via cyclooxygenase-1 induction of prostacyclin (Ospina et al, 2002) and/or by enhanced synthesis of nitric oxide (Geary et al, 2000;McNeill et al, 1999). Recent findings in humans indicate that increasing 17b-estradiol (E2) levels amplifies cerebral blood flow (CBF) (Slopien et al, 2003).…”
Section: Introductionmentioning
confidence: 99%